Point72 Asset Management
TNYA icon

Point72 Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Point72 Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.39K Buy
+11,346
New +$8.62K ﹤0.01% 3904
2026
Q1 		– Sell
-38,475
Closed -$27.4K – 4504
2025
Q4 		$27.4K Buy
+38,475
New +$52.3K ﹤0.01% 3822

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management's TNYA Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 11,346 shares worth $8.39K. The stake represents ﹤0.01% of the portfolio and ranks #3904 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in TNYA as recently as Q4 2025.

Point72 Asset Management first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $27.4K in Q4 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Point72 Asset Management held 11,346 shares of Tenaya Therapeutics worth $8.39K as of Q2 2026.
  • Tenaya Therapeutics was a new Point72 Asset Management position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3904 holding.
  • Point72 Asset Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's Tenaya Therapeutics position peaked at $27.4K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.